A Co-Doped Fe 3 O 4 Nanozyme Shows Enhanced Reactive Oxygen and Nitrogen Species Scavenging Activity and Ameliorates the Deleterious Effects of Ischemic Stroke
Yunsheng Liu,Xiaojun Wang,Xiangzhu Li,Shanshan Qiao,Guodong Huang,Dirk Matthias Hermann,Thorsten Roland Doeppner,Muling Zeng,Wei Liu,Gelin Xu,Lijie Ren,Yuan Zhang,Wenlan Liu,Eudald Casals,Weiping Li,Ya-Chao Wang
DOI: https://doi.org/10.1021/acsami.1c06449
2021-09-21
Abstract:Acute ischemic stroke has become the major cause of mortality and disability worldwide. Following ischemic stroke, the reperfusion injury is mainly mediated by the burst of reactive oxygen and nitrogen species (RONS). Therefore, blocking the excessive production or removing RONS holds great promise as a potential therapeutic strategy. Herein, we developed a Co-doped Fe3O4 nanozyme that is capable of scavenging H2O2, O2•–, •NO, and ONOO– in vitro and in vivo and provides neuroprotection against ischemic stroke. In vitro experiments showed that pre-incubation with the Co-Fe3O4 nanozyme could prevent neurotoxicity and neuroinflammation induced by H2O2 or lipopolysaccharide, respectively, in HT22 cells. After intravenous administration, the Co-Fe3O4 nanozyme showed no signs of toxicity in peripheral organs of C57BL/6J mice, even after prolonged delivery for 4 weeks. In permanent photothrombotic stroke model and transient middle cerebral artery occlusion stroke model, the Co-Fe3O4 nanozyme specifically accumulated in the infarct rim at 72 h post-stroke and was endocytosed by neurons, astrocytes, microglia, and endothelial cells. Importantly, the Co-Fe3O4 nanozyme delivery reduced the infarct volume in both stroke models. The observation that the Co-Fe3O4 nanozyme was efficacious in two well-characterized ischemic stroke models provides strong evidence that it represents a powerful tool for targeting oxidative and nitrosative stress in the ischemic brain.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c06449.Kinetic assay of the Co-Fe3O4 nanozyme; HT22 cell morphology; TEM image; effects of the Co-Fe3O4 nanozyme against LPS-induced cytotoxicity and ROS generation; stability of the Co-Fe3O4 nanozyme; H&E results of peripheral organs 24 and 72 h after stroke; IVIS Lumina result of Co-Fe3O4 in sham mice; success evaluation of the ischemic stroke model; distribution of Co-Fe3O4 nanozyme in stroke mice (15 min to 72 h); long-term distribution of Co-Fe3O4 nanozyme in stroke mice; long-term potential toxicity for peripheral organ results; body weight data; spatial memory assay; and prussian blue staining (PDF)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology